Permira names David Floyd as senior adviser

• Floyd currently serves as chairman of Corin Group, a portfolio company of Permira
• Floyd’s appointment follows the healthcare team’s recent appointment of Andy Eckert in 2022
• Permira is headquartered in London

Permira has appointed David Floyd as a senior adviser to its global Healthcare team.

Floyd previously served as worldwide president, DePuy Synthes, initially with US responsibility, and was then promoted to global responsibility.

Floyd currently serves as chairman of Corin Group, a tech-enabled orthopaedic implant company. Permira invested in Corin in 2018.

“His wealth of experience in the Medtech space in senior managerial roles and his expertise in building leading global businesses will be very valuable to the team as we continue to successfully invest in the attractive healthcare space,” said Silvia Oteri, partner and head of healthcare at Permira.

Floyd’s appointment follows the healthcare team’s recent appointment of Andy Eckert in 2022.

Permira, based in London, is a global private equity firm that invests in the healthcare sector.

The firm’s current investments in the health sector include, Kedrion and BPL, Neuraxpharm, Cambrex, Quotient Sciences, I-Med and Corin.